Playlist

Turkmenistan Explores Integration of Traditional Medicine into Child Healthcare Services

16 Apr. 10:50

Source

The Vice-President of the Gurbanguly Berdimuhamedov Charitable Foundation for Children in Need of Care, Oguljahan Atabayeva, recently held high-level discussions with a delegation from the Beijing University of Chinese Medicine. The meeting focused on the potential implementation of alternative medical practices to enhance pediatric healthcare and rehabilitation within the country. Both parties expressed a strong commitment to reviewing specialized proposals from Chinese experts regarding non-traditional treatment methods.

During the dialogue, the Turkmen side emphasized its interest in the unique achievements and specific therapeutic benefits of Eastern medicine. The focus is on how these methods can be adapted to support the health and recovery of children requiring specialized care. This initiative aims to broaden the scope of available medical treatments by integrating time-tested holistic approaches with modern clinical practice to ensure better outcomes for young patients.

The Rector of the Beijing University of Chinese Medicine praised Turkmenistan as a reliable international partner and underscored the global expansion of traditional medicine centers. He noted that similar facilities are already operating successfully in nations such as Germany, the United States, Russia, and Australia. The inclusion of Turkmenistan in this global network highlights the nation's proactive stance on adopting diverse and effective healthcare strategies for its population.

The Chinese delegation expressed their honor in contributing to the advancement of medical services in Turkmenistan, particularly in the field of child welfare. The talks concluded with an agreement to further explore cooperative frameworks and professional exchanges. This partnership is expected to introduce innovative rehabilitation techniques that will provide essential support to children under the care of the charitable foundation.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds

Today in 02:02

Source

Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.

Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌